Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients.

Elizabeth ParkJon T GilesThania Perez-RecioPaloma PinaChristopher DependerYevgeniya GartshteynAnca D AskanaseJoan BathonLaura Geraldino-Pardilla

Published in: Arthritis research & therapy (2021)

In a combined cohort of SLE and RA patients without clinical CVD, adjusted QTc length was comparable between HCQ and non-HCQ users, supporting its CV safety in patients with rheumatic diseases.

Keyphrases

end stage renal disease
systemic lupus erythematosus
newly diagnosed
chronic kidney disease
disease activity
prognostic factors
peritoneal dialysis